Enhanced CAR T-cell therapy shows early promise for B-cell cancers in first-in-human trial
Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers. The findings are published in Blood Cancer Discovery.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Smoking may affect fertility in both men and women
-
Doctors avoided two common words when talking about weight with patients
-
Experimental cataract lens can treat glaucoma through time-release drugs
-
How a common virus's hijack of cell repair processes may promote cancer
-
Disadvantaged children with intellectual disabilities face greater mental health difficulties, study finds
-
Marvel’s Wanda and Vision Trilogy Concludes with 8 Episodes of Paul Bettany-Led <i><em>VisionQuest </em></i>
-
Bigger data reveal the second, third and fourth switches controlling a gene
-
A closer look at endometriosis pain: New map reveals key cellular interactions